The hemostats market is expected to reach USD 3.03 billion by 2023 from USD 2.27 billion in 2018, at a CAGR of 6.0%

Thursday, September 20, 2018 Research News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, Sept. 19, 2018 /PRNewswire/ -- The global hemostats market is projected to grow at a CAGR of 6.0% during the forecast period.

Download the full report: https://www.reportbuyer.com/product/3641162 The hemostats market is expected to reach USD 3.03 billion by 2023 from USD 2.27 billion in 2018, at a CAGR
of 6.0%. Growth in this market is driven by the increasing number of surgical procedures, growing number of regulatory approvals, increasing incidence of sports-related injuries and spinal ailments, and rising focus on effective blood loss management in patients during surgeries.In 2018, the thrombin-based hemostats are expected to dominate the hemostats market.On the basis of product, the hemostats market is segmented into thrombin-based hemostats, oxidized regenerated cellulose-based hemostats, combination hemostats, gelatin-based hemostats, and collagen-based hemostats.In 2018, the thrombin-based hemostats segment is estimated to hold the largest share of the market.The large share of this segment is attributed to the wide range of advantages associated with the use of thrombin-based hemostats.The sponge hemostats segment is estimated to grow at the highest rate in the next five years.Based on formulation, the hemostats market has been segmented into matrix & gel hemostats, sheet & pad hemostats, sponge hemostats, and powder hemostats.The sponge hemostats segment is expected to witness the highest growth during the forecast period.The positive growth rate of this segment is attributed to the growing acceptance of these formulations by end users.Asia Pacific is estimated to grow at the highest CAGR during the study period.Geographically, the hemostats market was dominated by North America, followed by Europe in 2017.However, Asia Pacific is estimated to grow at the highest rate during the forecast period.The improving healthcare infrastructure, growing medical tourism, increasing number of elderly people in the region, and the implementation of favorable government initiatives in several Asian countries, are driving the growth of this region.The primary interviews conducted for this report can be categorized as follows:• By Company Type: Tier 1–70%, Tier 2–30%• By Designation: C level–62%, Director level–21%, Others–17%• By Region: North America–50%, Europe–20%, Asia Pacific–30%The key players in the hemostats market include CR Bard, Inc. (US). B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), Integra LifeSciences (US), Marine Polymer Technologies, Inc. (US), Teleflex (US), Ethicon, Inc. (US), Pfizer, Inc. (US), Z-Medica LLC (US), and Gelita Medical GmbH (Germany).Research Coverage:The report analyses the hemostats market by product, application, formulation, and region.Apart from a comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players over the last three years.In addition, the company profiles include product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the hemostats market.Key Benefits of Buying the Report:This report will enable both established firms as well as new entrants to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report can use one, or a combination of the below mentioned five strategies for strengthening their market shares.The report provides insights on the following pointers:• Market Penetration: Comprehensive information on the product portfolios of the top players in the hemostats market• Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the hemostats market• Competitive Assessment: In-depth assessment of the market strategies, geographic, and business segments and product portfolios of the leading players in the hemostats market• Market Development: Comprehensive information about emerging markets. This report analyzes the market for various hemostats products across geographies• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the hemostats marketDownload the full report: https://www.reportbuyer.com/product/3641162 About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: sarah@reportbuyer.com Tel: +1 (718) 213 4904 Website: www.reportbuyer.com

 

Cision View original content:http://www.prnewswire.com/news-releases/the-hemostats-market-is-expected-to-reach-usd-3-03-billion-by-2023-from-usd-2-27-billion-in-2018--at-a-cagr-of-6-0-300715591.html

SOURCE ReportBuyer



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store